Sit Coryfin Throat Oral Cavity Disinfectant 20 Tablets Of 0.25mg

NAME
CORYFIN THROAT 0.25 MG GOLD DISPERSIBLE TABLETS

PHARMACOTHERAPEUTIC CATEGORY
Prepare for the pharyngeal cavity.

ACTIVE PRINCIPLES
Dequalinium chloride.

EXCIPIENTS
Saccharin; sucrose; Arabic gum; vanillin; menthol; talc; magnesium stearate; compound aroma.

INDICATIONS
Disinfectant of the oral cavity.

CONTRAINDICATIONS / SECONDARY EFFECT
Hypersensitivity 'to the active substance or to any of the excipients.

DOSAGE
In pharyngeal and tonsillar inflammations 3 to 5 orodispersible tablets per day. The tablets should dissolve slowly in the mouth Do not exceed the recommended dose.

STORAGE
None.

WARNINGS
Pediatric population: for the presence of menthol in children under two years of age with a disposition to laryngospasm or convulsions, consult your doctor before using the product. Use similar caution in children up to six years of age. This product contains sucrose. Patients with rare hereditary problems of fructose intolerance, glucose-galactose malabsorption, or isomaltase insufficiency should not take this medicinal product. This medicine contains 1.2 g of sucrose per tablet. To be taken into consideration in people with diabetes mellitus.

INTERACTIONS
None known.

SIDE EFFECTS
Hypersensitivity phenomena may occur (skin rashes, etc.). The reporting of suspected adverse reactions that occur after the authorization of the drug is important, as it allows continuous monitoring of the benefit / risk ratio of the drug.

PREGNANCY AND BREASTFEEDING
During pregnancy, use for long periods must only take place on medical prescription; not to be used in the last month.